PRIVETERRA SPONSOR, LLCSponsor Share Arrangement • July 27th, 2023 • AEON Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 27th, 2023 Company IndustryThis letter agreement (the “Agreement”) is being made as of June 29, 2023, by and between ACM ASOF VIII Secondary-C LP (“Subscriber”) and Priveterra Sponsor, LLC (“Sponsor”). Capitalized terms used, but not otherwise defined herein, shall have the meaning given to them in the Subscription Agreement (as defined below).
PRIVETERRA SPONSOR, LLCSponsor Share Arrangement • June 30th, 2023 • Priveterra Acquisition Corp. • Pharmaceutical preparations
Contract Type FiledJune 30th, 2023 Company IndustryThis letter agreement (the “Agreement”) is being made as of June 29, 2023, by and between Polar Asset Management Partners (“Polar”) and Priveterra Sponsor, LLC (“Sponsor”). Capitalized terms used, but not otherwise defined herein, shall have the meaning given to them in the Subscription Agreement (as defined below).
PRIVETERRA SPONSOR, LLCSponsor Share Arrangement • July 27th, 2023 • AEON Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledJuly 27th, 2023 Company IndustryThis letter agreement (the “Agreement”) is being made as of June 29, 2023, by and between Polar Asset Management Partners (“Polar”) and Priveterra Sponsor, LLC (“Sponsor”). Capitalized terms used, but not otherwise defined herein, shall have the meaning given to them in the Subscription Agreement (as defined below).